Janet Napolitano - Aug 30, 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Aug 30, 2021
Transactions value $
-$13,647
Form type
4
Date filed
8/31/2021, 04:58 PM
Previous filing
Aug 4, 2021
Next filing
Nov 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Options Exercise $59.8K +1.44K +42.53% $41.64 4.81K Aug 30, 2021 Direct
transaction VIR Common Stock Sale -$73.4K -1.44K -29.84% $51.15 3.37K Aug 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Options Exercise $0 +1.44K +4.76% $0.00 31.6K Aug 30, 2021 Common Stock 1.44K $41.64 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2021.
F2 1/3 of the shares subject to the stock option vested and became exercisable on August 28, 2021, and the remaining shares vest in 24 equal monthly installments thereafter.